Common pathogenic mechanisms and pathways in the development of COPD and lung cancer

IA Yang, V Relan, CM Wright… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Lung cancer and COPD commonly coexist in smokers, and the presence of
COPD increases the risk of developing lung cancer. In addition to smoking cessation and …

[PDF][PDF] Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors

Y Lin, X Jiang, Y Shen, M Li, H Ma… - Endocrine-related …, 2009 - researchgate.net
Genetic alterations in the PIK3CA gene of the phosphoinositide 3-kinase (PI3K)/AKT
pathway have been found in many human tumors, but they have not been explored in …

Pulmonary adenocarcinoma: a renewed entity in 2011

H Kadara, M Kabbout, II Wistuba - Respirology, 2012 - Wiley Online Library
Lung cancer, of which non‐small‐cell lung cancer comprises the majority, is the leading
cause of cancer‐related deaths in the United States and worldwide. Lung adenocarcinomas …

[HTML][HTML] Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers

SY Lee, MJ Kim, G Jin, SS Yoo, JY Park, JE Choi… - Journal of thoracic …, 2010 - Elsevier
Introduction: Epidermal growth factor receptor (EGFR) signaling pathway plays a crucial role
in the development and progression of lung cancer. We searched for mutations of EGFR …

Expression signatures in lung cancer reveal a profile for EGFR‐mutant tumours and identify selective PIK3CA overexpression by gene amplification

B Angulo, A Suarez‐Gauthier… - The Journal of …, 2008 - Wiley Online Library
The development of targeted therapies creates a need to discriminate tumours accurately by
their histological and genetic characteristics. Here, we aim to identify gene expression …

[HTML][HTML] Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer

CQ Zhu, JC Cutz, N Liu, D Lau, FA Shepherd… - British journal of …, 2006 - nature.com
Telomerase reactivation is a hallmark of human carcinogenesis. Increased telomerase
activity may result from gene amplification and/or overexpression. This study evaluates the …

Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis

AT Ooi, AC Gower, KX Zhang, JL Vick, L Hong… - Cancer Prevention …, 2014 - AACR
Lung squamous cell carcinoma (SCC) is thought to arise from premalignant lesions in the
airway epithelium; therefore, studying these lesions is critical for understanding lung …

[HTML][HTML] Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)

M Ji, H Guan, C Gao, B Shi, P Hou - BMC cancer, 2011 - Springer
Background Lung cancer is the leading cause of cancer-related death worldwide. Genetic
and epigenetic alterations have been identified frequently in lung cancer, such as promoter …

PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress

P Wu, YZ Hu - Current medicinal chemistry, 2010 - ingentaconnect.com
The phosphoinositide 3-kinase (PI3K)/serine-theronine protein kinase Akt (also known as
protein kinase B (PKB))/mammalian target of rapamycin (mTOR) pathway is a vital …

Current concepts on the molecular pathology of non-small cell lung carcinoma

J Fujimoto, II Wistuba - Seminars in diagnostic pathology, 2014 - Elsevier
Recent advances in the understanding of the complex biology of non-small cell lung
carcinoma (NSCLC), particularly activation of oncogenes by mutation, translocation and …